{"id":36421,"date":"2024-10-23T10:01:56","date_gmt":"2024-10-23T08:01:56","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/?p=36421"},"modified":"2024-10-18T10:46:47","modified_gmt":"2024-10-18T08:46:47","slug":"frueh-uebt-sich","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2024\/frueh-uebt-sich","title":{"rendered":"Fr\u00fch \u00fcbt sich\u2026"},"content":{"rendered":"<p>Anders als in Europa sind in den USA die Zahlungen der Industrie an \u00c4rztinnen und \u00c4rzte transparent und bis zu jeder einzelnen Institution und Person in der \u201eOpen Payments Database\u201c nachvollziehbar . Im April haben wir dar\u00fcber berichtet, dass von diesen Geldfl\u00fcssen v.a. eine Minderheit profitiert und das negative Bild pr\u00e4gt (vgl.\u00a0). Etwa 6 von [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Anders als in Europa sind in den USA die Zahlungen der Industrie an \u00c4rztinnen und \u00c4rzte transparent und bis zu jeder einzelnen Institution und Person in der \u201eOpen Payments Database\u201c nachvollziehbar . Im April haben wir dar\u00fcber berichtet, dass von diesen Geldfl\u00fcssen v.a. eine Minderheit profitiert und das negative Bild pr\u00e4gt (vgl.\u00a0). Etwa 6 von [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[255,1452,257,843,846,1561],"class_list":["post-36421","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-arzneimittel","tag-interessenkonflikte","tag-medikamente","tag-pharmaindustrie","tag-pharmazeutische-unternehmer","tag-werbung"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/36421","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=36421"}],"version-history":[{"count":1,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/36421\/revisions"}],"predecessor-version":[{"id":36422,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/36421\/revisions\/36422"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=36421"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=36421"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=36421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}